Roche receives FDA 510(k) clearance for new cobas eplex Respiratory Pathogen Panel 3
Roche received FDA 510(k) clearance for its new cobas eplex Respiratory Pathogen Panel 3, which enables labs to customize respiratory testing for local patient needs.
1. FDA clearance
Roche said the FDA cleared its new cobas eplex Respiratory Pathogen Panel 3 under the 510(k) pathway, enabling labs to customize respiratory testing for local patient needs.
